Wednesday, February 8, 2017

Watchlist for Wednesday, February 08 $DRAM $CBIO $DRWI $RXII $LTBR $GENE $BBRY

Dataram Corp.
DRAM ----> Stock made a powerful trade session, crossing up all EMAs and its Upper Bollinger Band Line, closing in Breakout Mode, which happens over $1.76! Technical Indicators are showing a heavy Buying Pressure, which leads me to believe that we are on the verge of another monster Upside Move. Stay closely on this breakout.


Catalyst Bioscience Inc.
CBIO ---> Alerted for this setup on Twitter when it start to move up. It finished the day upping +19.77% ,crossing and closing above its 20EMA with high and pure Bullish Volume. Watching now for a possible break above its 50EMA.

DragonWave Inc.
DRWI ---> Extremely oversold Bottom Player that showed in last trade session unusual volume. Also, technical indicators are starting to curling up. We could be on the verge of a hard Bounce. Stay closely.

RXi Pharmaceuticals Corp.
RXII ---> This Bottom Player is ready To Fly after it had made yesterday a powerful trade session and Breakout with high Volume. I´ll be watching today for the confirmation of this Momentum! If it continue, we should see its 50EMA easily.

Lightbridge Corp.
LTBR ---> Nice Bottom Player with positive divergences on chart! I´m interesting to see the break above its 20EMA. It is gaining traction and on volume, it could move quickly to its 50EMA.

Genetic Technologies Ltd.
GENE ---> It got strong attention from the Buyers! As it close above its 20EMA with heavy volume, it could be now preparing the next move higher. A break above its 50EMA will make it in a strong Upside Runner Candidate. That is what i´m looking for today


BlackBerry
BBRY ---> Has been released news and price is gaining traction. Technical indicators are showing lots of buy signals and so, i´ll be watching for continuation. I expect a test to its 200EMA very soon.

Disclaimer

Here's a friendly reminder: all charts shared here are powerful tools based on major technical indicators. However, it's crucial to remember that stock suitability depends on your individual strategy. 🛠️ I must emphasize that good stock performance isn't solely determined by technical data. 💡 As always, trade cautiously, and I cannot be held responsible for any trade outcomes. Remember, I'm not a financial advisor.